Literature DB >> 3046563

Antibody response to wild rubella virus structural proteins following immunization with RA 27/3 live attenuated vaccine.

M G Cusi1, G M Rossolini, C Cellesi, P E Valensin.   

Abstract

Antibody response to individual structural proteins (E1, E2, and C) of the M-33 wild rubella virus strain was assayed by an immunoblot technique in 12 girls, following immunization with RA 27/3 live attenuated rubella vaccine. Of the 12 immunized subjects, before vaccination 9 had no demonstrable rubella specific antibodies while the remaining 3 had a low level of rubella specific antibodies, reacting only with the E1 protein. At one month after vaccination all the immunized subjects presented anti-E1, anti-E2, and anti-C specific antibodies. However, at 1-2 weeks after vaccination the 9 girls who were seronegative before immunization still had no detectable antibodies to any of the rubella virus structural proteins, while the 3 subjects whose preimmunization sera had reacted with the E1 protein presented an accelerated immune response, showing anti-E2 and anti-C specific antibodies and a more intensely marked anti-E1 specific band.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3046563     DOI: 10.1007/BF01314649

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  16 in total

1.  Rubella virus antigens: localization of epitopes involved in hemagglutination and neutralization by using monoclonal antibodies.

Authors:  K Y Green; P H Dorsett
Journal:  J Virol       Date:  1986-03       Impact factor: 5.103

2.  Specific antibody patterns over a two-year period after rubella immunization with RA 27/3 live attenuated vaccine.

Authors:  P E Valensin; G M Rossolini; M G Cusi; A Zanchi; C Cellesi; A Rossolini
Journal:  Vaccine       Date:  1987-12       Impact factor: 3.641

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Molecular and antigenic characteristics and synthesis of rubella virus structural proteins.

Authors:  R F Pettersson; C Oker-Blom; N Kalkkinen; A Kallio; I Ulmanen; L Kääriäinen; P Partanen; A Vaheri
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

6.  Structure and function of the rubella virus proteins.

Authors:  P H Dorsett; D C Miller; K Y Green; F I Byrd
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

7.  A model of the structural organization of rubella virions.

Authors:  M N Waxham; J S Wolinsky
Journal:  Rev Infect Dis       Date:  1985 Mar-Apr

8.  Immunochemical identification of rubella virus hemagglutinin.

Authors:  M N Waxham; J S Wolinsky
Journal:  Virology       Date:  1983-04-15       Impact factor: 3.616

9.  Rubella in teenagers: epidemiology and prophylaxis in Siena, Italy.

Authors:  C Cellesi; M L Bandinelli; M G Cusi; M L Di Cairano; P E Valensin; A Barberi; A Rossolini
Journal:  J Biol Stand       Date:  1985-10

10.  Rubella virus contains one capsid protein and three envelope glycoproteins, E1, E2a, and E2b.

Authors:  C Oker-Blom; N Kalkkinen; L Kääriäinen; R F Pettersson
Journal:  J Virol       Date:  1983-06       Impact factor: 5.103

View more
  13 in total

Review 1.  Rubella vaccines: past, present and future.

Authors:  J M Best
Journal:  Epidemiol Infect       Date:  1991-08       Impact factor: 2.451

2.  Detection of rubella virus-specific immunoglobulin G (IgG), IgM, and IgA antibodies by immunoblot assays.

Authors:  T Zhang; C A Mauracher; L A Mitchell; A J Tingle
Journal:  J Clin Microbiol       Date:  1992-04       Impact factor: 5.948

3.  Investigation into low-level anti-rubella virus IgG results reported by commercial immunoassays.

Authors:  Wayne Dimech; Nilukshi Arachchi; Jingjing Cai; Terri Sahin; Kim Wilson
Journal:  Clin Vaccine Immunol       Date:  2012-12-19

4.  Where to Now for Standardization of Anti-Rubella Virus IgG Testing.

Authors:  Wayne Dimech
Journal:  J Clin Microbiol       Date:  2016-05-11       Impact factor: 5.948

5.  Use of rubella virus E1 fusion proteins for detection of rubella virus antibodies.

Authors:  W G Starkey; J Newcombe; K M Corbett; K M Liu; P G Sanders; J M Best
Journal:  J Clin Microbiol       Date:  1995-02       Impact factor: 5.948

6.  Analysis of T- and B-cell epitopes of capsid protein of rubella virus by using synthetic peptides.

Authors:  D Ou; P Chong; B Tripet; S Gillam
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

7.  Possibility of reinfection after immunisation with RA27/3 live attenuated rubella virus.

Authors:  M G Cusi; P E Valensin; C Cellesi
Journal:  Arch Virol       Date:  1993       Impact factor: 2.574

8.  Reactivity of a recombinant rubella E1 antigen expressed in E. coli.

Authors:  P Londesborough; G Terry; L Ho-Terry
Journal:  Arch Virol       Date:  1992       Impact factor: 2.574

9.  Immune responses to wild and vaccine rubella viruses after rubella vaccination.

Authors:  M G Cusi; R Metelli; P E Valensin
Journal:  Arch Virol       Date:  1989       Impact factor: 2.574

Review 10.  Standardization of Assays That Detect Anti-Rubella Virus IgG Antibodies.

Authors:  Wayne Dimech; Liliane Grangeot-Keros; Christelle Vauloup-Fellous
Journal:  Clin Microbiol Rev       Date:  2016-01       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.